Sirius Therapeutics

Shanghai, China · Founded 2022 · In IPO Registration

Developer and researcher of novel RNAi therapies intended to treat chronic diseases. Sirius Therapeutics is based in Shanghai, China and was founded in 2022. Its last reported valuation was $253 million in May 2025. It has raised $214 million.

Last reported valuation

$252.5M

Oct 2026

Priced at

—

Total raised

$214.0M

Last round

—

How much has Sirius Therapeutics raised?

$214.0Macross 0 recorded rounds

Free account

More of Sirius Therapeutics with a free account

·Watch Sirius Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Sirius Therapeutics investors

7 investors are on record for Sirius Therapeutics, including OrbiMed, Hankang Capital, Image Frame Investment and BioTrack Capital.

For fundraisers

Raising for a company like Sirius Therapeutics?

7 investors have backed Sirius Therapeutics.

See all 7 investors →

Frequently asked about Sirius Therapeutics

How much has Sirius Therapeutics raised?: Sirius Therapeutics has raised $214.0M in total across 0 recorded funding rounds.